Phase 4Completed
Feasibility of Early Gabapentin as an Intervention for Neurorecovery
- Sponsor
- MetroHealth Medical Center (Academic or other)
- Enrolment
- 26 enrolled
- Conditions
- Spinal Cord Injuries
- Interventions
- Gabapentin; Placebo
- Ages
- adults, older adults
- Registry
- NCT05302999
Full record on ClinicalTrials.gov
From the registry
The objective of the proposed study is to conduct the first ever prospective, dose-exploration trial to test the feasibility of early administration of gabapentin as an intervention for neurorecovery. This research project falls under the Intervention Development stage of research as the primary goal is to assess the feasibility of conducting a well-designed intervention efficacy study in the future.
Primary outcomes
- Number of participants recruited
- Adherence rate to drug treatment protocol
- Number of occurrences of unblinding
- Retention rate
History
Last registry update
Study completion
Primary completion
Registered
Started